Most popular ETFs | ||||||
iShares Core MSCI World UCITS ETF USD (Acc) | IE00B4L5Y983 | Equity | ETF | |||
Xtrackers MSCI Emerging Markets UCITS ETF 1C | IE00BTJRMP35 | Equity | ETF | |||
Vanguard FTSE All-World UCITS ETF Distributing | IE00B3RBWM25 | Equity | ETF | |||
iShares Global Clean Energy UCITS ETF USD (Dist) | IE00B1XNHC34 | Equity | ETF | |||
HSBC FTSE 100 UCITS ETF GBP | IE00B42TW061 | Equity | ETF |
Most popular categories |
Equity, World |
Equity, Dividend strategy |
Bonds, UK Gilts |
The Global X Genomics & Biotechnology UCITS ETF seeks to track the Solactive Genomics index. The Solactive Genomics index tracks companies active in the fields of genomics and biotechnology.
Replication |
Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Long-only |
Fund currency | USD |
Currency risk |
Currency unhedged |
Volatility 1 year (in GBP) |
39.68%
![]() |
Inception/ Listing Date | 2 November 2021 |
Distribution policy | Accumulating |
Distribution frequency | - |
Fund domicile | Ireland |
Fund Structure | - |
UCITS compliance | Yes |
Fund Provider | Global X |
Administrator | SEI Investments – Global Fund Services Limited |
Investment Advisor | |
Custodian Bank | Brown Brothers Harriman & Co. |
Revision Company | PwC |
Fiscal Year End | - |
Swiss representative | 1741 Fund Solutions AG |
Swiss paying agent | Tellco AG |
Germany | 30% tax rebate |
Switzerland | ESTV Reporting |
Austria | Tax Reporting Fund |
UK | UK Reporting |
Indextype | Total return index |
Swap counterparty | - |
Collateral manager | |
Securities lending | Yes |
Securities lending counterparty |
Below you find information about the composition of the Global X Genomics & Biotechnology UCITS ETF.
IE00BM8R0N95 |
100.00%
|
Other |
100.00%
|